Citigroup
STJ

Citigroup’s St Jude Medical STJ Stock Holding History

Citigroup’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-75,700
Closed -$6.07M – 7541
2016
Q4 		$6.07M Sell
75,700
-24,500
-24% -$1.94M 0.01% 1620
2016
Q3 		$7.99M Buy
100,200
+20,400
+26% +$1.65M 0.01% 1249
2016
Q2 		$6.22M Buy
79,800
+43,600
+120% +$3.11M 0.01% 1377
2016
Q1 		$1.99M Sell
36,200
-23,000
-39% -$1.25M ﹤0.01% 2492
2015
Q4 		$3.66M Buy
59,200
+4,300
+8% +$271K ﹤0.01% 1976
2015
Q3 		$3.46M Sell
54,900
-27,400
-33% -$1.96M ﹤0.01% 1984
2015
Q2 		$6.01M Sell
82,300
-2,200
-3% -$159K 0.01% 1583
2015
Q1 		$5.53M Sell
84,500
-60,300
-42% -$4.01M 0.01% 1651
2014
Q4 		$9.42M Buy
144,800
+100
+0.1% +$6.44K 0.01% 1323
2014
Q3 		$8.7M Sell
144,700
-8,800
-6% -$575K 0.01% 1404
2014
Q2 		$10.6M Buy
153,500
+21,300
+16% +$1.38M 0.01% 1222
2014
Q1 		$8.64M Sell
132,200
-41,400
-24% -$2.69M 0.01% 1269
2013
Q4 		$10.8M Sell
173,600
-39,600
-19% -$2.29M 0.01% 1184
2013
Q3 		$11.4M Buy
213,200
+125,100
+142% +$6.44M 0.01% 1065
2013
Q2 		$4.02M Buy
+88,100
New +$3.82M ﹤0.01% 1814

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Citigroup's STJ Position: Q1 2017 in Review

Citigroup sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 4,594,746 shares — an estimated $368M sold.

Citigroup first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $368M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Citigroup reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Citigroup sold 4,594,746 St Jude Medical shares in Q1 2017, an estimated $368M.
  • Citigroup first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Citigroup's St Jude Medical position peaked at $368M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Citigroup's 13F filing for Q1 2017, filed 12 May 2017.